leisure time -WSS

leisure time

author：explore 2025-09-30 15:16:00 - browse：284

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Mike Pence clashes with Tucker Carlson in Iowa

knowledge

WSS

Who gets to use the title 'doctor'?

Paxlovid study fails to answer questions over benefit for broader groups

Why we need to separate burnout from moral injury in health care

J&J expands global access to TB drug amid advocacy campaign

Donald Trump's relentless attacks on special counsel Jack Smith

Involuntary treatment for addiction doesn't work

entertainment

leisure time

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Death of patient in Alzheimer’s trial raises question of possible risks

New air purifier tech could be key to improving indoor air quality

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Sports medicine is finally prioritizing gender equality

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

DIEP, the 'gold standard' of breast reconstruction, is under threat

Colonoscopy at 40? Study finds a possible benefit

BioMarin wins approval for gene therapy to treat hemophilia A

#NeedHerScience: shining a light on gender disparities in medicine

hotspot

Colonoscopy at 40? Study finds a possible benefit

In areas with more Black doctors, Black people live longer

3 hurdles to bringing medical devices to the U.S. market

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Donald Trump's relentless attacks on special counsel Jack Smith

Europe sees delivery challenges ahead on Alzheimer's therapies

Wikipedia

knowledge

Wikipedia

focus